AI Stock Analysis - Resmed (RMD)
Analysis generated September 10, 2025.
Resmed is a global leader in the development and manufacturing of medical devices and cloud-connected software applications aimed at improving the quality of life for the people who suffer from sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company has a strong commitment to research and development, enabling it to continually innovate and offer advanced solutions in its field.
Stock Alerts - Resmed (RMD)
 |
Resmed | January 21 Employee Rating is up by 2.5% over the last month. |
|
Resmed | January 10 Insider Alert: FARRELL PETER C is selling shares |
|
Resmed | January 9 Insider Alert: Farrell Michael J. is selling shares |
|
Resmed | January 6 Insider Alert: Rider Michael J is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Resmed
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 456 | Sign up | Sign up | Sign up |
| Sentiment | 95 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,756,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 169 | Sign up | Sign up | Sign up |
| Facebook Followers | 176,541 | Sign up | Sign up | Sign up |
| Instagram Followers | 10,446 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,046 | Sign up | Sign up | Sign up |
| X Followers | 10,894 | Sign up | Sign up | Sign up |
| X Mentions | 4 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 57,100 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 77 | Sign up | Sign up | Sign up |
| Linkedin Employees | 8,641 | Sign up | Sign up | Sign up |
About Resmed
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
| Price | $255.50 |
| Target Price | Sign up |
| Volume | 1,090,000 |
| Market Cap | $36.8B |
| Year Range | $240.87 - $293.03 |
| Dividend Yield | 0.86% |
| PE Ratio | 25.83 |
| Analyst Rating | 50% buy |
| Earnings Date | January 29 '26 |
| Industry | Medical Devices |
In the news
 |
ResMed Inc.'s (NYSE:RMD) Stock Has Fared Decently: Is the Market Following Strong Financials?January 23 - Yahoo |
|
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseJanuary 21 - Yahoo |
|
Should ResMed's (RMD) Earnings Beat and Margin Gains Require Action From Investors?January 15 - Yahoo |
|
A Look At ResMed (RMD) Valuation After Earnings Beat And Strong Start To Fiscal 2026January 15 - Yahoo |
|
Is It Time To Reassess ResMed (RMD) After Recent Sleep Care Tailwinds?January 15 - Yahoo |
|
Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)January 14 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 1.34B | 515M | 821M | 349M | 503M | 2.550 |
| Q2 '25 | 1.35B | 528M | 820M | 380M | 532M | 2.550 |
| Q1 '25 | 1.29B | 525M | 766M | 365M | 470M | 2.370 |
| Q4 '24 | 1.28B | 531M | 751M | 345M | 479M | 2.430 |
| Q3 '24 | 1.22B | 507M | 717M | 311M | 443M | 2.200 |
Insider Transactions View All
| FARRELL PETER C filed to sell 66,773 shares at $248.8. January 9 '26 |
| Farrell Michael J. filed to sell 466,223 shares at $248.5. January 8 '26 |
| Sandercock Brett filed to sell 86,495 shares at $241.8. January 5 '26 |
| Rider Michael J filed to sell 9,741 shares at $241.8. January 5 '26 |
| Farrell Michael J. filed to sell 466,223 shares at $251.4. December 9 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Kelly Louise Morrison |
Jun 19, 25 | Sell | $1K - $15K |
| Kelly Morrison |
May 14, 25 | Sell | $1K - $15K |
| Kelly Louise Morrison |
May 14, 25 | Sell | $1K - $15K |
Read more about Resmed (RMD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Resmed
The Market Cap of Resmed is $36.8B.
As of today, Resmed's PE (Price to Earnings) ratio is 25.83.
Resmed will report its next earnings on January 29 '26.
Currently, the price of one share of Resmed stock is $255.50.
The RMD stock price chart above provides a comprehensive visual representation of Resmed's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Resmed shares. Our platform offers an up-to-date RMD stock price chart, along with technical data analysis and alternative data insights.
Yes, Resmed (RMD) offers dividends to its shareholders, with a dividend yield of 0.86%. This dividend yield represents Resmed's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Resmed in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Resmed are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
